Vera Bril

Active 1983–2025

144
Papers
20,089
Citations
75
h-index
137
i10-index

Citations

Citations per year for Vera Bril1975: 1 citations1985: 2 citations1986: 3 citations1987: 4 citations1988: 6 citations1989: 6 citations1990: 12 citations1991: 9 citations1992: 11 citations1993: 3 citations1994: 9 citations1995: 14 citations1996: 6 citations1997: 11 citations1998: 10 citations1999: 15 citations2000: 19 citations2001: 22 citations2002: 15 citations2003: 27 citations2004: 33 citations2005: 43 citations2006: 65 citations2007: 74 citations2008: 69 citations2009: 93 citations2010: 72 citations2011: 77 citations2012: 79 citations2013: 108 citations2014: 110 citations2015: 113 citations2016: 88 citations2017: 108 citations2018: 131 citations2019: 581 citations2020: 682 citations2021: 697 citations2022: 592 citations2023: 489 citations2024: 1,008 citations2025: 481 citations2026: 11 citations1976–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,330 citing papers, 21.6% of this breakdownUnited Kingdom: 592 citing papers, 9.6% of this breakdownChina: 458 citing papers, 7.4% of this breakdownGermany: 393 citing papers, 6.4% of this breakdownItaly: 340 citing papers, 5.5% of this breakdownCanada: 270 citing papers, 4.4% of this breakdownNetherlands: 206 citing papers, 3.3% of this breakdownJapan: 200 citing papers, 3.3% of this breakdownAustralia: 189 citing papers, 3.1% of this breakdownFrance: 179 citing papers, 2.9% of this breakdownSpain: 148 citing papers, 2.4% of this breakdownDenmark: 142 citing papers, 2.3% of this breakdown
0%21.6%Other 27.8%

Fields

  • Medicine83%
  • Biochemistry, Genetics and Molecular Biology8.5%
  • Neuroscience2.7%
  • Immunology and Microbiology2.1%
  • Health Professions1%
  • Engineering0.8%
  • Other1.9%

Topics

  • Pain Mechanisms and Treatments9.5%
  • Peripheral Neuropathies and Disorders6.4%
  • Myasthenia Gravis and Thymoma6.1%
  • Diabetic Foot Ulcer Assessment and Management3.8%
  • Botulinum Toxin and Related Neurological Disorders3.2%
  • Peripheral Nerve Disorders2.4%
  • Other68.6%

Coauthors

All papers

Open in search
  1. Diabetic Neuropathy: A Position Statement by the American Diabetes Association

    Authors: , , , , , , , - Diabetes Care 2016 cited by 2,466

  2. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela Genge, Zaeem A. Siddiqi, Jana Junkerová, Jana Hořáková, Katerina Reguliova, Michaela Týblová, Ivana Jurajdova, Iveta Nováková, Michala Jakubíková, Jiří Piťha, Stanislav Voháňka, Katerina Havelkova, Tomáš Horák, Josef Bednařík, Mageda Horakova, Andreas Meisel, Dike Remstedt, Claudia Heibutzki, Siegfried Köhler, Lea Gerischer, Sarah Hoffman, Frauke Stascheit, John Vissing, Lizzie Zafirakos, Kuldeep Kumar Khatri, Anne Ostergaard Autzen, Mads Stemmerik, Henning Andersen, Shahram Attarian, Emmanuelle Salort‐Campana, Émilien Delmont, Aude‐Marie Grapperon, Ludivine Kouton, Alexander Tsiskaridze, Csilla Rózsa, Gedeonne Jakab, Szilvia Z. Tóth, G Szabó, David Bors, Enikő Szabó, Angela Campanella, Fiammetta Vanoli, Rita Frangiamore, Carlo Antozzi, Silvia Bonanno, Lorenzo Maggi, Riccardo Giossi, Francesco Saccà, Angela Marsili, Chiara Pane, Giorgia Puorro, Antonio Reia, Giovanni Antonini, Girolamo Alfieri, Stefania Morino, Matteo Garibaldi, Laura Fionda, Luca Leonardi, Shingo Konno, Akiyuki Uzawa, Kaoru Sakuma, Chiho Watanabe, Yukiko Ozawa, Manato Yasuda, Yosuke Onishi, Makoto Samukawa, Tomoko Tsuda, Yasushi Suzuki, Sayaka Ishida, Genya Watanabe and 118 more - The Lancet Neurology 2021 cited by 668

  3. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julia Wanschitz, Wolfgang N. Löscher, Jan De Bleecker, Guy Van den Abeele, Kathy de Koning, Katrien De Mey, Rudy Mercelis, Linda Wagemaekers, Délphine Mahieu, Philip Van Damme, Charlotte Smetcoren, Olivier Stevens, Sarah Verjans, Ann D’Hondt, Petra Tilkin, Alzira Alves de Siqueira Carvalho, Rosa Hasan, Igor Dias Brockhausen, David Feder, Daniel Ambrosio, Ana Paula Souto Melo, Rosana Rocha, Bruno Bezerra Rosa, Thabata Veiga, Luiz Augusto da Silva, Jordana Gonçalves Geraldo, Maria da Penha Morita Ananias, Érica Nogueira Coelho, Gabriel Pina Paiva, M Tovar Pozo, Natália Prando, Debora Dada Martineli Torres, Cristiani Fernanda Butinhao, Érica Nogueira Coelho, Luciana Renata Cubas Volpe, Gustavo Duran, Tamires Cristina Gomes da Silva, Luiz Otavio Maia Gonçalves, Lucas Eduardo Pazetto, Luciana Souza Duca, Tomás Augusto Suriane Fialho, Maurício Friedrich, Alexandre Guerreiro, Henrique Mohr, Maurer Pereira Martins, Daiane da Cruz Pacheco, Ana Paula Macagnan, Aline de Cassia Santos, Acary Souza Bullé Oliveira, Ana Carolina Amaral de Andrade, Marcelo Annes, Valéria Cavalcante Lino, Wladimir Bocca Vieira de Rezende Pinto, Carolina Miranda, Fernanda Carrara, Iandra Souza, Angela Genge, Rami Massie, Natasha Campbell, Vera Bril, Hans Katzberg, Mehran Soltani, Eduardo Ng, Zaeem A. Siddiqi, Celile Phan, Derrick Blackmore, Stanislav Voháňka, Josef Bednařík, Magda Chmelikova, Marek Čierny and 524 more - The Lancet Neurology 2017 cited by 800

  4. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stéphan A. Botez, Michaela Týblová, Michala Jakubíková, Jana Junkerová, John Vissing, Nanna Witting, Sonja Holm‐Yildiz, Mads Stemmerik, Henning Andersen, Izabella Obál, Guilhem Solé, Stéphane Mathis, Marie‐Hélène Violleau, Christine Tranchant, Sihame Messai, Jean‐Baptiste Chanson, Aleksandra Nadaj‐Pakleza, Arnaud Verloes, Leila Zaidi, Sabrina Sacconi, Manuela Gambella, Michele Cavalli, Tanya Stojkovic, Sophie Demeret, Loïc Le Guennec, Giorgia Querin, Nicolas Weiss, Marion Masingue, Laurent Magy, Karima Ghorab, Ia Rukhadze, Alexander Tsiskaridze, Marina Janelidze, Temur Margania, Florian Then Bergh, Eike Hänsel, Andrea Kalb, Bianca Meilick, Mandy Reuschel, Lars-Malte Teußer, Astrid Unterlauft, Clemens Goedel, Tim Hagenacker, Andreas Totzeck, Benjamin Stolte, Franz Blaes, Christine Bindler, Vasilios Tsoutsikas, Annekathrin Roediger, Christian Geis, Jens Schmidt, Jana Zschüntzsch, Margret Schwarz, Stefanie Meyer, Karsten Kummer, Stefanie Glaubitz, Rachel Zeng, Heinz Wiendl, Luisa Klotz, Anna Lammerskitten, Jan D. Lünemann, Péter Diószeghy, Renato Mantegazza, Lorenzo Maggi, Elena Rinaldi, Matteo Gastaldi, Federico Mazzacane, Pietro Businaro, Raffaele Iorio, Giovanni Antonini and 193 more - The Lancet Neurology 2023 cited by 260

  5. Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , NEURO-TTRansform Investigators, Anna Mazzeo, Aikaterini Papagianni, Mazen M. Dimachkie, Ioannis Zaganas, Edward Gane, Marco Luigetti, Lucía Galán Dávila, Michelle M. Mezei, Juan González Moreno, Pascal Cintas, Davide Pareyson, Rebecca Traub, Julie Khoury, Conrado J. Estol, Merrilee Needham, David Adams, Michael Polydefkis, Thomas H. Brannagan, Vera Bril, Shahram Attarian, Marcelo Rugiero, B. Jane Distad, Eleni Zamba Papanicolaou, Kon‐Ping Lin, Merrill D. Benson, Morton Scheinberg - JAMA 2023 cited by 207

  6. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jerrica Farias, Rita Frangiomore, Sarah Heintsman, Robert H.P. de Meel, Manisha Chopra, Paolo Emilio Alboini, Angela Genge - Neurology 2019 cited by 288

  7. Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals

    Authors: , - Drugs 2022 cited by 129

  8. Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis

    Authors: , , , , , , , , , , - Neurology 2020 cited by 140

  9. Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

    Authors: , , , , , , , , , , , , , , , , , - Frontiers in Neurology 2024 cited by 71

  10. Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary

    Authors: , , , , , , , , , , , , , , , , , , - Neurology 2021 cited by 167

  11. Diabetic Neuropathies

    Authors: , , , , , , , , , - Diabetes Care 2005 cited by 1,836

  12. International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Muscle & Nerve 2016 cited by 156

  13. Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders

    Authors: , , , , , - The Lancet Neurology 2022 cited by 108

  14. Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis

    Authors: , , , , , , , , , , , , , , , , - Neurology 2023 cited by 72

  15. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity

    Authors: , , , , , , , , , , - Diabetes/Metabolism Research and Reviews 2011 cited by 492

  16. Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvia Bonanno, Angela Campanella, Tiyonnoh Cash, Bakri Elsheikh, Vittorio Frasca, Namita Goyal, Brittany Harvey, Eugene C. Lai, Lorenzo Maggi, Brian Minton, Verónica Puertas‐Martín, Emanuela Onesti, Mamatha Pasnoor, Gulmohor Roy, Sheetal Shroff, Jason R. Thonhoff - Neurology 2018 cited by 128

  17. Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]

    Authors: , , , , , , , , , , - Neurology 2011 cited by 630

  18. Comparison of IVIg and PLEX in patients with myasthenia gravis

    Authors: , , , , - Neurology 2011 cited by 351

  19. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toomas Toomsoo, Inna Rubanovits, Katrin Gross‐Paju, Ulvi Sorro, M. Saarela, Mari Auranen, Jean Pouget, Shahram Attarian, Gwendal Le Masson, Anne-Cécile Wielanek-Bachelet, Claude Desnuelle, Émilien Delmont, Pierre Clavelou, D Aufauvre, Jens Schmidt, Jana Zschuentssch, Claudia Sommer, Daniela Kramer, Olaf Hoffmann, Carsten Goerlitz, Jürgen Haas, Marios Chatzopoulos, Richard S. Yoon, Ralf Gold, Peter Berlit, Andrea Jaspert-Grehl, David Liebetanz, Anna Kutschenko, Martin Stangel, Corinna Trebst, Petra Baum, Florian Then Bergh, Juliane Klehmet, Andreas Meisel, Fabian Klostermann, Johanna Oechtering, Helmar C. Lehmann, Michael Schroeter, Tim Hagenacker, Daniel Mueller, A.D Sperfeld, F. Bethke, Vivian E. Drory, Avi A. Algom, David Yarnitsky, Beth B. Murinson, Antonio Di Muzio, Fausta Ciccocioppo, Sandro Sorbi, Sabrina Matà, Angelo Schenone, Marina Grandis, Giuseppe Lauria, Daniele Cazzato, Giovanni Antonini, Stefania Morino, Dario Cocito, Maurizio Zibetti, Takanori Yokota, Takuya Ohkubo, Takashi Kanda, M Kawai, Kenichi Kaida, Hiroyuki Onoue, Satoshi Kuwabara, Masahiro Mori, Masahiro Iijima, Ken Ohyama, Masayuki Baba, Masahiko Tomiyama and 50 more - The Lancet Neurology 2017 cited by 269

  20. Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy

    Authors: , - Diabetes Care 2002 cited by 457

  21. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

    Authors: , , , , , , , , , - The Lancet Neurology 2008 cited by 669

  22. Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy

    Authors: , , , , - Diabetic Medicine 2009 cited by 220

  23. Novel Treatments in Myasthenia Gravis

    Authors: , , - Frontiers in Neurology 2020 cited by 101

  24. The genomic landscape of schwannoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 cited by 188